139 related articles for article (PubMed ID: 29097308)
21. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
[TBL] [Abstract][Full Text] [Related]
22. Structures of the entire human opioid receptor family.
Wang Y; Zhuang Y; DiBerto JF; Zhou XE; Schmitz GP; Yuan Q; Jain MK; Liu W; Melcher K; Jiang Y; Roth BL; Xu HE
Cell; 2023 Jan; 186(2):413-427.e17. PubMed ID: 36638794
[TBL] [Abstract][Full Text] [Related]
23. Preclinical studies of opioids and opioid antagonists on gastrointestinal function.
Greenwood-Van Meerveld B; Gardner CJ; Little PJ; Hicks GA; Dehaven-Hudkins DL
Neurogastroenterol Motil; 2004 Oct; 16 Suppl 2():46-53. PubMed ID: 15357851
[TBL] [Abstract][Full Text] [Related]
24. Naloxone rapidly evokes endogenous kappa opioid receptor-mediated hyperalgesia in naïve mice pretreated briefly with GM1 ganglioside or in chronic morphine-dependent mice.
Crain SM; Shen KF
Brain Res; 2007 Sep; 1167():31-41. PubMed ID: 17692296
[TBL] [Abstract][Full Text] [Related]
25. Role of the thalamic submedius nucleus histamine H1 and H 2 and opioid receptors in modulation of formalin-induced orofacial pain in rats.
Erfanparast A; Tamaddonfard E; Taati M; Dabaghi M
Naunyn Schmiedebergs Arch Pharmacol; 2015 Oct; 388(10):1089-96. PubMed ID: 26077661
[TBL] [Abstract][Full Text] [Related]
26. Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in mu opioid receptor-G protein coupling and Gbetagamma signaling.
Wang HY; Friedman E; Olmstead MC; Burns LH
Neuroscience; 2005; 135(1):247-61. PubMed ID: 16084657
[TBL] [Abstract][Full Text] [Related]
27. Differential effects of mu-, delta-, and kappa-opioid receptor agonists on mechanosensitive gastric vagal afferent fibers in the rat.
Ozaki N; Sengupta JN; Gebhart GF
J Neurophysiol; 2000 Apr; 83(4):2209-16. PubMed ID: 10758129
[TBL] [Abstract][Full Text] [Related]
28. [Significance of opioid receptors in regulation of cardiac tolerance in pathogenic impact of long-term ischemia-reperfusion in vivo].
Maslov LN; Barzakh EI; Krylatov AV; Brown SA; Oeltgen PR; Govindaswami M; Chernysheva GA; Solenkova NV; Lishmanov AIu; Tsibul'nikov SIu; Krieg T; Zhang E
Ross Fiziol Zh Im I M Sechenova; 2009 Jun; 95(6):563-72. PubMed ID: 19639880
[TBL] [Abstract][Full Text] [Related]
29. Analysis of natural product regulation of cannabinoid receptors in the treatment of human disease.
Badal S; Smith KN; Rajnarayanan R
Pharmacol Ther; 2017 Dec; 180():24-48. PubMed ID: 28583800
[TBL] [Abstract][Full Text] [Related]
30. The opioid system in the gastrointestinal tract.
Sternini C; Patierno S; Selmer IS; Kirchgessner A
Neurogastroenterol Motil; 2004 Oct; 16 Suppl 2():3-16. PubMed ID: 15357847
[TBL] [Abstract][Full Text] [Related]
31. Ultra-low dose naloxone restores the antinociceptive effect of morphine in pertussis toxin-treated rats by reversing the coupling of mu-opioid receptors from Gs-protein to coupling to Gi-protein.
Tsai RY; Tai YH; Tzeng JI; Cherng CH; Yeh CC; Wong CS
Neuroscience; 2009 Dec; 164(2):435-43. PubMed ID: 19682558
[TBL] [Abstract][Full Text] [Related]
32. An opioid agonist that does not induce mu-opioid receptor--arrestin interactions or receptor internalization.
Groer CE; Tidgewell K; Moyer RA; Harding WW; Rothman RB; Prisinzano TE; Bohn LM
Mol Pharmacol; 2007 Feb; 71(2):549-57. PubMed ID: 17090705
[TBL] [Abstract][Full Text] [Related]
33. Opioid antinociception in a rat model of visceral pain: systemic versus local drug administration.
Craft RM; Henley SR; Haaseth RC; Hruby VJ; Porreca F
J Pharmacol Exp Ther; 1995 Dec; 275(3):1535-42. PubMed ID: 8531126
[TBL] [Abstract][Full Text] [Related]
34. Voltage-Gated R-Type Calcium Channel Inhibition via Human μ-, δ-, and κ-opioid Receptors Is Voltage-Independently Mediated by Gβγ Protein Subunits.
Berecki G; Motin L; Adams DJ
Mol Pharmacol; 2016 Jan; 89(1):187-96. PubMed ID: 26490245
[TBL] [Abstract][Full Text] [Related]
35. mu- but not delta- and kappa-opioid receptors in the ventrolateral orbital cortex mediate opioid-induced antiallodynia in a rat neuropathic pain model.
Zhao M; Wang JY; Jia H; Tang JS
Brain Res; 2006 Mar; 1076(1):68-77. PubMed ID: 16476416
[TBL] [Abstract][Full Text] [Related]
36. Endogenous opiates and behavior: 2012.
Bodnar RJ
Peptides; 2013 Dec; 50():55-95. PubMed ID: 24126281
[TBL] [Abstract][Full Text] [Related]
37. Dualism, allosteric modulation, and biased signaling of opioid receptors: Future therapeutic potential.
González AM; Jubete AG
Rev Esp Anestesiol Reanim (Engl Ed); 2024 Apr; 71(4):298-303. PubMed ID: 37683976
[TBL] [Abstract][Full Text] [Related]
38. Antinociceptive effects of the 6-O-sulfate ester of morphine in normal and diabetic rats: Comparative role of mu- and delta-opioid receptors.
Yadlapalli JSK; Ford BM; Ketkar A; Wan A; Penthala NR; Eoff RL; Prather PL; Dobretsov M; Crooks PA
Pharmacol Res; 2016 Nov; 113(Pt A):335-347. PubMed ID: 27637375
[TBL] [Abstract][Full Text] [Related]
39. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.
Yamada H; Shimoyama N; Sora I; Uhl GR; Fukuda Y; Moriya H; Shimoyama M
Brain Res; 2006 Apr; 1083(1):61-9. PubMed ID: 16530171
[TBL] [Abstract][Full Text] [Related]
40. Allosteric Modulation of Opioid G-Protein Coupled Receptors by Sigma
Pasternak GW
Handb Exp Pharmacol; 2017; 244():163-175. PubMed ID: 28667477
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
